ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 294 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $11,733,000 | -36.7% | 290,249 | -9.9% | 0.01% | -28.6% |
| Q2 2015 | $18,534,000 | -43.4% | 322,056 | -37.3% | 0.01% | -46.2% |
| Q1 2015 | $32,724,000 | +60.9% | 513,961 | +56.1% | 0.01% | +62.5% |
| Q4 2014 | $20,332,000 | +63.7% | 329,318 | +2.9% | 0.01% | +60.0% |
| Q3 2014 | $12,422,000 | -4.1% | 319,918 | -14.9% | 0.01% | 0.0% |
| Q2 2014 | $12,951,000 | -26.4% | 375,944 | -7.7% | 0.01% | -28.6% |
| Q1 2014 | $17,608,000 | +18.2% | 407,498 | +8.9% | 0.01% | +16.7% |
| Q4 2013 | $14,902,000 | +9.9% | 374,036 | +3.6% | 0.01% | 0.0% |
| Q3 2013 | $13,554,000 | +54.5% | 361,033 | +10.6% | 0.01% | +50.0% |
| Q2 2013 | $8,771,000 | – | 326,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |